Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models (Q37610100)
Jump to navigation
Jump to search
scientific article published on 21 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models |
scientific article published on 21 October 2013 |
Statements
1 reference
Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models (English)
1 reference
Anjali Apte
1 reference
Erez Koren
1 reference
Alexander Koshkaryev
1 reference
Vladimir P Torchilin
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference